Brainstorm Cell Therapeutics Inc (FRA:GHDN)
€ 0.398 -0.045 (-10.16%) Market Cap: 28.78 Mil Enterprise Value: 29.09 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 38/100

Brainstorm Cell Therapeutics Inc at EBD Group Biotech Showcase Transcript

Jan 09, 2023 / 06:30PM GMT
Release Date Price: €1.42 (+0.11%)
Operator

So, the next presenting company is Brainstorm Cell Therapeutics from New York, New York, United States. Brainstorm Cell Therapeutics is focused on CNS, neurological, gene, cell therapy, inflammation. Presenting for Brainstorm Cell Therapeutics are their CEO, Chaim Lebovits and Co-CEO, Dr. Stacy Lindborg.

Chaim Lebovits
Brainstorm Cell Therapeutics Inc. - CEO

Good morning, Dr. Stacy Lindborg is my Co-CEO as of late weeks or so. And so we don't want to change the presentation or send someone else presently, so we can do this together.

This is a very exciting moment for us. And I'm sure many of you know that late in the week, we are having a meeting with the FDA Type A meeting. But for now, we'll be focusing and explaining our narrative of our data where we think the approvals kind of warranted here. And just we'll -- Stacy please take the floor and [we'll do slides] and now I will jump in different slides. Right.

Dr. Stacy Lindborg
Brainstorm Cell Therapeutics Inc. - Co-CEO

Sure, thank you. Pleasure to see

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot